quinoxalines has been researched along with Cataract, Membranous in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bauters, G; Borderie, V; Bouheraoua, N; Paques, M | 1 |
| Balbaba, M; Çelebi, S; Ulaş, F | 1 |
| Artunay, O; Bahcecioglu, H; Rasier, R; Sengul, A; Unal, M; Yuzbasioglu, E | 1 |
| Hall, D; Prok, L | 1 |
| Heimann, K; Hoernchen, H; Merz, U; Peschgens, T; Wenzl, T | 1 |
| Asano, T; Fukushi, S; Irinoda, K; Ishikawa, S; Miyata, M; Mizuno, K; Sato, Y; Suzuki, T; Watanabe, H; Yonechi, K | 1 |
3 trial(s) available for quinoxalines and Cataract, Membranous
| Article | Year |
|---|---|
Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cataract; Cloprostenol; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pain; Phacoemulsification; Postoperative Period; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost | 2013 |
Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Capsule Opacification; Cataract; Cloprostenol; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Posterior Capsule of the Lens; Quinoxalines; Tonometry, Ocular | 2010 |
[Clinical evaluation of Azapentacene in senile cataract--a double-blind controlled study].
Topics: Adult; Aged; Cataract; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines | 1984 |
3 other study(ies) available for quinoxalines and Cataract, Membranous
| Article | Year |
|---|---|
Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases.
Topics: Cataract; Glaucoma, Angle-Closure; Humans; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Retrospective Studies | 2021 |
A 24-day old with episodic lethargy, hypotonia, and apnea: the eyes have it.
Topics: Adrenergic alpha-Agonists; Apnea; Brimonidine Tartrate; Cataract; Humans; Infant, Newborn; Male; Muscle Hypotonia; Quinoxalines; Sleep Stages | 2003 |
[Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].
Topics: Antihypertensive Agents; Apnea; Brimonidine Tartrate; Cataract; Female; Glaucoma; Humans; Infant, Newborn; Infant, Premature, Diseases; Neurotoxicity Syndromes; Ophthalmic Solutions; Postoperative Complications; Quinoxalines; Respiratory Insufficiency; Trabeculectomy | 2007 |